Freeflow Ventures

← Back to your selection

Activity in this selectiondolby-family-ventures-4eebc2d3

Rounds participated in: 3
Confirmed lead rounds: —
New companies: 3
Funding in participating rounds: $18.2M

By stage

Pre-seed1

Seed1

Series A1

By primary sector

Biotech3

By country

United States3

Rounds

3 in this selection

Mar 31

TippingPoint Biosciences

Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer

$4.5MSeed

Role not disclosed

Feb 18

Sift Biosciences

Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases

$3.7MPre-Seed

Role not disclosed

Jan 13

Vivere Oncotherapies

Develops cancer therapies that activate the immune system to detect and destroy cancer cells in t...

$10MSeries A

Role not disclosed